Minorities’ participation in clinical trials is often an issue of debate among the clinical research industry. Anyway, most of us agree that their participation is crucial in order to develop better treatments for everybody. That’s why as part of ...
Hispanics and Diabetes People with Hispanic or Latino backgrounds are at higher risk for developing type 2 diabetes than non-Hispanic Caucasians. This is a fact that researchers have long known. However, most research has looked at this group as a ...
Understanding the issue Clinical trials are the key to find and learn about the consequences of new medical treatments in people’s well-being. Some of them focus on patient’s safety and treatment effectiveness, others are just observational. These ...
It’s no secret that the recruitment process is often the most difficult part for a clinical trial. Just to give an example, let’s analyze a report from the Pharmaceutical Technology website. The report states that 15 – 20% of trials never enroll a si ...
Friday, June 30, 2017, after two years, MINSA has issued a new regulation of clinical studies, through D.S. No. 021-2017-SA which replaces Supreme Decree No. 017-2006-SA and repeals D.S. N ° 020-2015-SA established the moratorium on clinical studies ...
Latin America has become a great ally for clinicians when developing Clinical Trials. This region provides many advantages and facilities other regions just can't match. With over 20 countries spanning from Mexico in North America to Chile and Argent ...
Minority participation in clinical trials is an important topic in public health discussions. This representation touches on issues of equality and the elimination of disparities, which are core values of the field. The FDA Safety and Innovation Act ...
Starting from the fact that minorities account for fewer than 10 percent of patients enrolled in clinical trials. Health disparities and underrepresentation in clinical trials could become a serious issue in the upcoming years. FDA Regulations In ...
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced a significant reductio ...
Minorities, in fact, account for fewer than 10 percent of patients enrolled in clinical trials, according to the National Institutes of Health (NIH) National Institute on Minority Health and Health Disparities. Today, Wilkins brings together academic ...